Solvable Problems in Diabetes at EASD 2024

Solvable Problems Header Graphic with Name and Date of event, repeated below

Join us for a festive social gathering and enlightening panel discussion, moderated by Professor Helen Murphy

Wednesday, September 11, 2024 at 6:45pm CEST

Palacio Neptuno
Calle de Cervantes 42, Centro
28014 Madrid, Spain

This is a ticketed event to benefit the non-profit work of diaTribe. A limited number of complimentary tickets are available for EASD faculty and session presenters. (Use coupon code FACULTY at check out. Eligibility for complimentary tickets will be checked at door.) Deeply discounted tickets are also available for all clinicians, researchers, and non-profit advocates without the need of a coupon code. Please contact Rachel Allen with questions.

REGISTER HERE

Advancements in CGM and AID technology, along with more stable insulins, have made pregnancy much less risky than in the past for women with diabetes, but there are still challenges to be addressed and improvements that can be made. Esteemed women at the forefront of diabetes and pregnancy research and care, led by Professor Helen Murphy (University of East Anglia, UK), will discuss where we are today and what can be done in the future to improve outcomes for mothers and their newborns. Panelists include Dr. Ananta Addala (Stanford University, USA), midwife Dawn Adams (Ulster University, Northern Ireland), Prof. Elisabeth R. Mathiesen (University of Copenhagen, Denmark), and Dr. Arianne Sweeting (University of Sydney, Australia).

Join us for an evening of food, drink, exceptional networking and learning.

If your company is an event sponsor (below), please email Rachel Allen to learn if there might still be sponsor tickets available for your company.

REGISTER HERE

PANEL CHAIR and MODERATOR

Helen Murphy, MBBChBAO, FRACP, MD

Professor of Medicine, at the University of East Anglia, UK
Clinician, Norfolk & Norwich University Hospital NHS Trust, UK

Dr. Helen Murphy is a Professor of Medicine (Diabetes and Antenatal Care) at the University of East Anglia, and a practising clinician (Norfolk & Norwich University Hospital NHS Trust), Norwich, UK. She runs a diabetes pregnancy research program which aims to support women with diabetes to achieve the pregnancy glucose targets required for optimal mother and baby health outcomes. She co-led the CONCEPTT Continuous Glucose Monitoring (CGM) trial. CONCEPTT demonstrated health benefits for mothers with type 1 diabetes (T1D), their newborn infants and the potential for substantial healthcare cost savings. In addition to scientific contributions, building research infrastructure and supporting the next generation of clinical academics, data from CONCEPTT led to international changes in clinical practice, CGM is now the recognised standard of care for pregnant women with T1D.

Her work with Professor Roman Hovorka demonstrating that hybrid closed-loop systems could transform the future clinical management of T1D during pregnancy was published in the New England Journal of Medicine. Based on these landmark studies, the CamAPS FX closed-loop system is licensed for use during T1D pregnancy and endorsed by the 2023 NICE TA for women who are pregnant or planning pregnancy.

Helen also serves as clinical lead for the National Pregnancy in Diabetes (NPID) audit, which is the largest population-based study in diabetes pregnancy. Data from NPID directly informs national healthcare policy, highlighting the urgent need to improve glycaemic management in type 2 diabetes (T2D) pregnancy. Supported by JDRF, Diabetes UK, and the NIHR, her research is changing the management of diabetes in pregnancy. Helen serves on several research committees, the editorial board for Diabetes Care, Diabetologia, and is a regular contributor to national and international scientific meetings.

PANELISTS

Dawn Adams, B. Sc Midwifery Sciences

Queen's University Belfast, Northern Ireland
Ulster University, Northern Ireland

Dawn was diagnosed with Type 1 Diabetes in 1993. After the birth of her fourth son she retrained as Midwife. Extended roles as a Diabetes Link Midwife and Antenatal Education Midwife for Women with Diabetes have further developed her clinical understanding of diabetes on pregnancy outcomes for mothers and babies.

She is an invited lecturer and course facilitator in diabetes education for pre- and post-registration nurses, midwives, and pharmacists through Queen’s University Belfast, Ulster University, and the Clinical Education Centre. She is a Diabetes Network Board Member and a member of the Diabetes and Pregnancy Subgroup.

She has presented work on Type 1 Diabetes and the Use of Wearable Technologies in Pregnancy at the 3rd IEEE International Conference on Bioinformatics and Bioengineering (BIBE) in 2019, Type 1 Diabetes and Wearable Technologies in Pregnancy at the 32nd ICM Triennial Congress of Midwives in 2021, and Technology: Changes in Diabetes Treatment at the All-Ireland Maternity and Midwifery Conference in 2023.

Ananta Addala, MD, MPH

Assistant Professor, Stanford University

Dr. Ananta Addala is a pediatric endocrinologist and physician scientist at Stanford University addressing disparities in pediatric type 1 diabetes management and outcomes. As a physician with a background in pediatric endocrinology, epidemiology, and behavioral health, she aims to build an evidence-based approach to addressing T1D disparities by systematically evaluating youth-, family-, provider-, and system-level barriers to optimal diabetes care in youth from low socioeconomic and racial/ethnic minority groups.

She is funded by NIDDK K23 to understand and address disparities in pediatric diabetes technology access and utilization. She also has funding from the Maternal Child Research Institute and Helmsley Charitable Trust. To date, her publications have demonstrated that the disparities in pediatric T1D by socioeconomic status are worsening in the US, provider bias against public insurance is common, and public insurance mediated interruptions to diabetes technology adversely impact glycemic outcomes. She has also been leading the efforts to improve justice, equity, diversity, and inclusion in research at Stanford University through her leadership at Stanford Pediatrics Advancing Anti-Racism Coalition and as the co-chair of TrialNet's Underrepresented Minorities Outreach Committee.

Prof. Elisabeth R. Mathiesen

Professor in Endocrinology, University of Copenhagen
Chief Endocrinologist at Center for Pregnant Women with Diabetes
at Rigshospitalet, Copenhagen, Denmark

Prof. Mathiesen’s initial research dealt with prevention of late diabetic complications, with focus on hypertension and diabetic nephropathy. During the last 30 years her research has focused on modalities to improve pregnancy outcomes in women with diabetes by reducing complications such as congenital malformations, preeclampsia, preterm delivery and fetal overgrowth. Prevention and treatment of gestational diabetes, as well as the long-term outcomes of the offspring of a diabetic mother, have also been part of her investigations. Prof. Mathiesen has supervised more than 70 Ph.D. and Master projects. She has published more than 260 original scientific papers in international scientific journals including high ranked journals such as the Lancet, NEJM, BMJ, Diabetes Care, and Diabetologia. She has been invited to write reviews in Nature Reviews Endocrinology and Diabetes Care, and several chapters in national and international textbooks of internal medicine, diabetology and obstetrics.

Dr. Arianne Sweeting

Senior Lecturer, Faculty of Medicine and Health, University of Sydney, Australia
Endocrinologist, Royal Prince Alfred Hospital, Australia

Dr. Arianne Sweeting is a clinical academic endocrinologist at the University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia. She is committed to optimising women’s health through her clinical work and research, establishing and leading her Metabolic Health in Pregnancy clinical research program, and publishing extensively in the field of early gestational diabetes. Arianne is a member of the International Association of the Diabetes in Pregnancy Study Groups (IADPSG), Chair of the American Diabetes Association /European Association for the Study of Diabetes Precision Medicine in Diabetes Initiative (ADA/EASD PMDI) Gestational Diabetes Diagnosis Working Group and the immediate Past President and Chair of the Australasian Diabetes in Pregnancy Society (ADIPS). Her international leadership and research aims to revolutionize the way we diagnose and treat diabetes in pregnancy, addressing the intergenerational burden of metabolic disease.